Regeneron Pharmaceuticals, Inc.

UNITED CAPITAL FINANCIAL ADVISORS, LLC REGN

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/17/2026

Shares

2,982

Value ($000)

2,302

Weight

0.0%

2019 Q3 - 2025 Q4 (26 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/17/2026	2,302	0.0%	2,982	12/31/2025
2025 Q3	11/14/2025	1,446	0.0%	2,571	9/30/2025
2025 Q2	8/11/2025	1,173	0.0%	2,234	6/30/2025
2025 Q1	5/13/2025	1,494	0.0%	2,356	3/31/2025
2024 Q4	2/13/2025	1,688	0.0%	2,370	12/31/2024
2024 Q3	11/12/2024	3,155	0.0%	3,001	9/30/2024
2024 Q2	8/14/2024	3,182	0.0%	3,027	6/30/2024
2024 Q1	5/15/2024	2,883	0.0%	2,995	3/31/2024
2023 Q4	2/14/2024	2,926	0.0%	3,331	12/31/2023
2023 Q3	11/14/2023	3,651	0.0%	4,437	9/30/2023
2023 Q2	8/14/2023	3,355	0.0%	4,669	6/30/2023
2023 Q1	8/15/2023	3,775	0.0%	4,595	3/31/2023
2022 Q4	2/15/2023	2,695	0.0%	3,736	12/31/2022
2022 Q3	11/14/2022	1,074	0.0%	1,560	9/30/2022
2022 Q2	8/11/2022	891	0.0%	1,508	6/30/2022
2022 Q1	5/16/2022	1,087	0.0%	1,557	3/31/2022
2021 Q4	2/14/2022	1,028	0.0%	1,629	12/31/2021
2021 Q3	11/15/2021	1,038	0.0%	1,715	9/30/2021
2021 Q2	8/13/2021	1,078	0.0%	1,931	6/30/2021
2021 Q1	5/14/2021	1,095	0.0%	2,314	3/31/2021
2020 Q4	2/17/2021	1,146	0.0%	2,372	12/31/2020
2020 Q3	11/13/2020	1,170	0.0%	2,091	9/30/2020
2020 Q2	8/13/2020	1,265	0.0%	2,029	6/30/2020
2020 Q1	8/11/2020	586	0.0%	1,200	3/31/2020
2019 Q4	2/14/2020	332	0.0%	886	12/31/2019
2019 Q3	2/14/2020	101	0.0%	364	9/30/2019